# A Study to Investigate the Safety, Tolerability, Food Effect, Pharmacokinetics and Pharmacodynamics of FOR-6219

> **NCT03709420** · PHASE1 · COMPLETED · sponsor: **Forendo Pharma Ltd** · enrollment: 87 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** Placebo
- **DRUG:** FOR-6219

## Key facts

- **NCT ID:** NCT03709420
- **Lead sponsor:** Forendo Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-13
- **Primary completion:** 2020-11-11
- **Final completion:** 2020-11-11
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2020-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03709420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03709420, "A Study to Investigate the Safety, Tolerability, Food Effect, Pharmacokinetics and Pharmacodynamics of FOR-6219". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03709420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*